Picton Mahoney Asset Management lifted its holdings in shares of Revance Therapeutics, Inc. ( NASDAQ:RVNC – Get Rating ) by 62.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 99,980 shares of the biopharmaceutical company's stock after buying an additional 38,580 shares during the period. Picton Mahoney Asset Management owned approximately 0.12% of Revance Therapeutics worth $1,844,000 at the end of the most recent reporting period.

https://www.dailypolitical.com/2023/06/03/revance-therapeutics-inc-nasdaqrvnc-shares-acquired-by-picton-mahoney-asset-management.html

#dailypolitical